USE OF A PEPTIDE AS A THERAPEUTIC AGENT

摘要

The present invention is directed to the use of the combination of the peptide compounds Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys- Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 and Tyr-Gly-Gly-Phe- Leu-Arg-Lys-Tyr-Pro-Lys-OH as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease.